Breaking News Instant updates and real-time market news.

ATNM

Actinium Pharmaceuticals

$0.42

-0.015 (-3.49%)

07:41
03/13/18
03/13
07:41
03/13/18
07:41

Actinium announces FDA clearance for Actimab-A/CLAG-M Phase 1 combo trial

Actinium Pharmaceuticals announced that the Medical College of Wisconsin received clearance from the FDA for the previously announced Investigational New Drug, or IND, application for the Phase 1 trial of Actimab-A in combination with CLAG-M for relapsed or refractory Acute Myeloid Leukemia, or AML, patients. This investigator initiated trial will be conducted at the Medical College of Wisconsin and led by principal investigator Dr. Sameem Abedin in collaboration with Dr. Ehab Atallah. This trial will enroll up to 18 patients and will assess safety as well as efficacy, which will be based on response rates, percentage of patients receiving a bone marrow transplant and overall survival. Actimab-A is an antibody radio-conjugate, or ARC, that combines the anti-CD33 antibody lintuzumab with the radioisotope actinium-225. CLAG-M is a salvage chemotherapy regimen consisting of cladribine, cytarabine, filgrastim and mitoxantrone that has become the standard of care at many institutions across the U.S. in AML patients with relapse.

  • 13

    Mar

ATNM Actinium Pharmaceuticals
$0.42

-0.015 (-3.49%)

09/14/17
MAXM
09/14/17
INITIATION
Target $3
MAXM
Buy
Actinium Pharmaceuticals initiated with a Buy at Maxim
Maxim analyst Jason McCarthy started Actinium Pharmaceuticals with a Buy rating and $3 price target, saying he believes the company's Iomab-B treatment could become the new standard of care in bone marrow transplants. He predicts that success in acute myeloid leukemia will lead to expansion of the use of Iomab-B to multiple other cancers.
10/23/17
ROTH
10/23/17
INITIATION
Target $6
ROTH
Buy
Actinium Pharmaceuticals resumed with a Buy at Roth Capital
Roth Capital analyst Jotin Marango resumed coverage of Actinium Pharmaceuticals with a Buy rating and $6 price target as he believes it offers discounted entry into clinical-stage AML biologics.
12/06/17
RILY
12/06/17
INITIATION
Target $2.75
RILY
Buy
Actinium Pharmaceuticals initiated with a Buy at B. Riley FBR
B. Riley FBR analyst George Zavoico started Actinium Pharmaceuticals with a Buy rating and $2.75 price target. The analyst believes the company's antibody-radioisotope conjugates may change the standard of care.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/14/18
12/14
12:17
12/14/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/14/18
12/14
12:16
12/14/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.26

-14.54 (-9.84%)

, SBUX

Starbucks

$64.61

-2.29 (-3.42%)

12:15
12/14/18
12/14
12:15
12/14/18
12:15
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened lower…

JNJ

Johnson & Johnson

$133.26

-14.54 (-9.84%)

SBUX

Starbucks

$64.61

-2.29 (-3.42%)

ADBE

Adobe

$233.37

-14.34 (-5.79%)

COST

Costco

$207.71

-18.7 (-8.26%)

BEL

Belmond

$24.67

7 (39.62%)

LVMUY

LVMH

$0.00

(0.00%)

KANG

iKang Healthcare

$20.30

2.03 (11.11%)

IDRA

Idera Pharmaceuticals

$5.34

-1.26 (-19.09%)

CDE

Coeur Mining

$3.89

-0.165 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

PFE

Pfizer

$43.45

-1.105 (-2.48%)

12:14
12/14/18
12/14
12:14
12/14/18
12:14
Hot Stocks
Pfizer announces new $10B share repurchase program »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.52

-1.03 (-2.31%)

12:13
12/14/18
12/14
12:13
12/14/18
12:13
Hot Stocks
Pfizer raises quarterly dividend 6% to 36c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.52

-1.03 (-2.31%)

12:12
12/14/18
12/14
12:12
12/14/18
12:12
Hot Stocks
Breaking Hot Stocks news story on Pfizer »

Pfizer boosts dividend to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ECA

Encana

$5.93

-0.295 (-4.74%)

12:10
12/14/18
12/14
12:10
12/14/18
12:10
Options
Call buyers in Encana as shares suffer additional losses »

Call buyers in Encana as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$2.76

0.02 (0.73%)

12:08
12/14/18
12/14
12:08
12/14/18
12:08
Hot Stocks
CVI Investments reports 9.9% passive stake in Tonix Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYH

Community Health

$3.94

-0.45 (-10.25%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
Community Health falls -10.2% »

Community Health is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$132.65

-15.15 (-10.25%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
Johnson & Johnson falls -10.3% »

Johnson & Johnson is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$101.00

-17 (-14.41%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -14.4% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIVI

Civitas Solutions

$14.68

2.05 (16.23%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
Civitas Solutions rises 14.6% »

Civitas Solutions is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

SPY

SPDR S&P 500 ETF Trust

$262.10

-3.31 (-1.25%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Options
$10.5M sweep of SPDR 500 Trust upside calls »

$10.5M sweep of SPDR 500…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$73.25

9.63 (15.14%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 14.7% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEL

Belmond

$24.69

7.015 (39.70%)

12:00
12/14/18
12/14
12:00
12/14/18
12:00
Hot Stocks
Belmond rises 39.8% »

Belmond is up 39.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$51.75

-0.45 (-0.86%)

, T

AT&T

$30.21

0.3 (1.00%)

11:56
12/14/18
12/14
11:56
12/14/18
11:56
On The Fly
Box Office Battle: 'Spider-Man: Into the Spider-Verse' swings into theaters »

Welcome to "Box Office…

SNE

Sony

$51.75

-0.45 (-0.86%)

T

AT&T

$30.21

0.3 (1.00%)

CMCSA

Comcast

$36.68

-0.07 (-0.19%)

CMCSK

Comcast

$0.00

(0.00%)

DIS

Disney

$113.21

-0.17 (-0.15%)

FOXA

21st Century Fox

$49.26

0.13 (0.26%)

FOX

21st Century Fox

$49.02

0.14 (0.29%)

LGF.A

Lionsgate

$16.00

0.25 (1.59%)

LGF.B

Lionsgate

$14.90

0.3 (2.05%)

VIA

Viacom

$31.85

0.22 (0.70%)

VIAB

Viacom

$29.28

0.41 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 30

    Jan

  • 20

    Mar

EPD

Enterprise Products

$26.15

-0.15 (-0.57%)

11:55
12/14/18
12/14
11:55
12/14/18
11:55
Options
Enterprise Products put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

NTR

Nutrien

$47.01

-0.02 (-0.04%)

11:49
12/14/18
12/14
11:49
12/14/18
11:49
Hot Stocks
Nutrien increases existing share repurchase program »

Nutrien announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNC

Lincoln National

$54.54

0.11 (0.20%)

11:48
12/14/18
12/14
11:48
12/14/18
11:48
Hot Stocks
Lincoln Financial appoints Leon Roday as General Counsel »

Lincoln Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$131.24

-16.56 (-11.20%)

11:44
12/14/18
12/14
11:44
12/14/18
11:44
Recommendations
Johnson & Johnson analyst commentary  »

J&J $40B loss in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWFT

Swift Transportation

$0.00

(0.00%)

, WERN

Werner

$30.52

-0.48 (-1.55%)

11:41
12/14/18
12/14
11:41
12/14/18
11:41
Hot Stocks
DOJ sues freight companies for systematic overcharging of shipments »

The United States has…

SWFT

Swift Transportation

$0.00

(0.00%)

WERN

Werner

$30.52

-0.48 (-1.55%)

JBHT

J.B. Hunt

$93.32

-2.57 (-2.68%)

ODFL

Old Dominion

$125.75

-0.79 (-0.62%)

KNX

Knight-Swift

$26.88

-0.44 (-1.61%)

ARCB

ArcBest

$35.22

-0.38 (-1.07%)

YRCW

YRC Worldwide

$4.13

-0.3 (-6.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$93.98

-0.37 (-0.39%)

11:40
12/14/18
12/14
11:40
12/14/18
11:40
Options
Lowes calls active »

Lowes calls active.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

JNJ

Johnson & Johnson

$132.94

-14.86 (-10.05%)

11:38
12/14/18
12/14
11:38
12/14/18
11:38
Recommendations
Johnson & Johnson analyst commentary  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTX

Leap Therapeutics

$2.92

0.07 (2.46%)

11:36
12/14/18
12/14
11:36
12/14/18
11:36
Conference/Events
Leap Therapeutics to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

11:35
12/14/18
12/14
11:35
12/14/18
11:35
General news
President Trump says 'China wants to make a big' trade deal »

President Donald Trump…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$262.91

-2.5 (-0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.